Similar articles

• [Disappearance of serum autoantibodies during treatment with interferon alpha in a patient with chronic hepatitis C].

  Khemissa F, Bauget P, Michel H, Larrey D. Khemissa F, et al. Gastroenterol Clin Biol. 1997;21(12):998-9. Gastroenterol Clin Biol. 1997. PMID: 9587568 French. No abstract available.
• Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients.

  Floreani A, Chiaramonte M, Greggio NA, Fabris P, De Lazzari F, Naccarato R, Betterle C. Floreani A, et al. Ital J Gastroenterol Hepatol. 1998 Feb;30(1):71-6. Ital J Gastroenterol Hepatol. 1998. PMID: 9615270
• Interferon treatment of children with chronic hepatitis C.

  al-Tawil Y, Nelson C. al-Tawil Y, et al. Hepatogastroenterology. 1998 Mar-Apr;45(20):345-8. Hepatogastroenterology. 1998. PMID: 9638404 Review.
• Autoimmune thrombocytopenic purpura and dermatomyositis associated with chronic hepatitis C. A therapeutic dilemma.

  Moccia F. Moccia F. Ann Ital Med Int. 1998 Oct-Dec;13(4):240-3. Ann Ital Med Int. 1998. PMID: 10349207
• Treatment of autoimmune and extra-hepatic manifestations of HCV infection.

  Lunel F, Cacoub P. Lunel F, et al. Ann Med Interne (Paris). 2000 Feb;151(1):58-64. Ann Med Interne (Paris). 2000. PMID: 10761564 Review.